Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-25

Clinical Trial Update: High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial exploring high-dose chemotherapy with amifostine and autologous stem cell transplantation for high-risk relapsed pediatric solid and brain tumors;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Solid Tumors, Brain Tumors | Phase 2 | Status: TERMINATED | Results posted: 2022-01-25